The Diabetic Pancreas: A Pathologist’s View

  • J. Rahier

Abstract

The morphology of the pancreas in human diabetes has long received much attention. In 1845, more than 40 years before Von Mering and Minkowski [105] demonstrated that pancreatectomy results in the advent of diabetes, autopsy findings had led Bouchardat to the concept that diabetes is a pancreatic disease [11]. From this time on, many studies have improved our knowledge of the normal and diabetic pancreas. The most decisive one was the discovery of the islets by Langerhans in 1869 [51], followed, 30 years later, by the recognition of their heterogeneous composition [16]. In the early 1920s islet abnormalities were detected in the pancreas of diabetic patients [12, 49, 67, 90]. In 1951, about 30 years after the discovery of insulin by Banting and Best [3], the development of a bioassay for this hormone permitted differentiation of different forms of diabetes [9].

Keywords

Obesity Pancreatitis Fibril Hyperglycemia Amylase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adler G, Kern HF (1975) Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metabol Res 7: 290–296CrossRefGoogle Scholar
  2. 2.
    Alumets J, Hakanson R, Lundqvist G, Sundler F, Thorell J (1980) Ontogeny and ultrastructure of somatostatin and calcitonin cells in the thyroid gland of the rat. Cell Tissue Res 206: 193–201PubMedCrossRefGoogle Scholar
  3. 3.
    Banting FG, Best CH (1922) The internal secretion of the pancreas. J Lab Clin Med 7: 251–266Google Scholar
  4. 4.
    Bartow SA, Mukai K, Rosai J (1981) Pseudoneoplastic proliferation of endocrine cells in pancreatic fibrosis. Cancer 47: 2627–2633PubMedCrossRefGoogle Scholar
  5. 5.
    Bell ET (1953) The incidence and significance of degranulation of the B cells in diabetes mellitus. Diabetes 2:125–129PubMedGoogle Scholar
  6. 6.
    Bell ET (1959) Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol 35: 801–805PubMedGoogle Scholar
  7. 7.
    Berson S, Yalow R (1961) Plasma insulin in health and disease. Am J Med 31: 882PubMedCrossRefGoogle Scholar
  8. 8.
    Bloom A, Haes TM, Gamble DR (1975) Register of newly diagnosed diabetic children. Br Med J 3: 580–583PubMedCrossRefGoogle Scholar
  9. 9.
    Bornstein J, Lawrence RD (1951) Plasma insulin in human diabetes mellitus. Br Med J 1: 1541–1548CrossRefGoogle Scholar
  10. 10.
    Bottazzo GF, Pujoll Borell R, Hanafusa T (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115–1119PubMedCrossRefGoogle Scholar
  11. 11.
    Bouchardat A (1845) ***Die pathologisch-anatomischen Veränderungen des Pankreas beim Diabetes mellitus. In: Henke F, Lubarsch O (eds) Handbuch der speziellen Pathologischen Anatomie und Histologie. Julius Springer, Berlin, vol 5, Part 2: 622–747 *** Quoted by Kraus EJ (1929)Google Scholar
  12. 12.
    Cecil RL (1909) A study of the pathological anatomy of the pancreas in 90 cases of diabetes mellitus. J Exp Med 2: 266CrossRefGoogle Scholar
  13. 13.
    Cerasi E, Luft R, Efendic S (1972) Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. Diabetes 21: 224–234PubMedGoogle Scholar
  14. 14.
    Cudworth AG (1978) Type 1 diabetes mellitus. Diabetologia 14: 281–291PubMedCrossRefGoogle Scholar
  15. 15.
    Defronzo RA, Ferrannini E, Koivisto V (1983) New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med, Diabetes Symposium, 52–76Google Scholar
  16. 16.
    Diamare V (1889) Studi comparativi sulle isole di Langerhans del pancreas. Mem La Int Monat Anat Physiol 16:155–208Google Scholar
  17. 17.
    Doniach I, Morgan AG (1973) Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol: 233–248Google Scholar
  18. 18.
    Fajans SS (1983) Heterogeneity of diabetes mellitus. In: Mngola EN (ed) Diabetes 1982. Excerpta Medica, Amsterdam, pp 229–235Google Scholar
  19. 19.
    Filosa S, Pictet R, Rutter WJ (1975) Positive control of cyclic AMP on mesenchymal factor controlled DNA synthesis in embryonic pancreas. Nature 257: 702–704PubMedCrossRefGoogle Scholar
  20. 20.
    Foo Y, Rosalki SB, Ramdial L, Mikhailidis D, Dandona P (1980) Serum isoamylase activities in diabetes mellitus. J Clin Pathol 33:1102–1105PubMedCrossRefGoogle Scholar
  21. 21.
    Foulis AK, Stewart JA (1984) The pancreas in recent-onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26: 456–461PubMedCrossRefGoogle Scholar
  22. 22.
    Fujita T (1966) D-Zellen der Pankreasinseln beim Diabetes mellitus mit besonderer Berücksichtigung ihrer Argyrophilie. Z Zellforsch 69: 363–370PubMedCrossRefGoogle Scholar
  23. 23.
    Gepts W (1958) Die histopathologischen Veränderungen der Langerhansschen Inseln und ihre Bedeutung in der Frage der Pathogenese des menschlichen Diabetes. Endokrinologie 36:185-211PubMedGoogle Scholar
  24. 24.
    Gepts W (1965) Pathological anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMedGoogle Scholar
  25. 25.
    Gepts W, De Mey J, Marichal-Pipeleers M (1977) Hyperplasia of “pancreatic polypeptide” cells in the pancreas of juvenile diabetics. Diabetologia 13: 27–34PubMedCrossRefGoogle Scholar
  26. 26.
    Gepts W, De Mey J (1978) Islet cell survival determined by morphology. An immunocytochemical study of the islet of Langerhans in juvenile diabetes mellitus. Diabetes 27 [Suppl 1]: 251–261PubMedGoogle Scholar
  27. 27.
    Gepts W, LeCompte PH (1981) The pancreatic islets in diabetes. Am J Med 70:105–115PubMedCrossRefGoogle Scholar
  28. 28.
    Gepts W (1982) Pathology of the pancreas in diabetes. In: Brodoff BN, Bleicher SJ (eds) Diabetes mellitus and obesity. Williams and Wilkins, Baltimore, pp 622–633Google Scholar
  29. 29.
    Gorsuch AN, Lister J, Dean BM, Spencer KM, McNally JM, Bottazzo GF (1981) Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 19/26: 1363–1366CrossRefGoogle Scholar
  30. 30.
    Gorsuch AN, Spencer KM, Lister J, Wolf E, Bottazzo GF, Cudworth AG (1982) Can future type diabetes be predicted? A study in families of affected children. Diabetes 31: 862–867PubMedCrossRefGoogle Scholar
  31. 31.
    Greenberg GR, Mitznegg P, Bloom SR (1977) Effect of pancreatic polypeptide on DNA-synthesis in the pancreas. Experienta 33:1332–1333CrossRefGoogle Scholar
  32. 32.
    Halter JB, Graf RJ, Porte D (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946–954PubMedCrossRefGoogle Scholar
  33. 33.
    Hellman B, Wallgren A, Peterson B (1962) Cytological characteristics of the exocrine pancreatic cells with regard to their position in relation to the islets of Langerhans. Acta Endocrinol 39:465–473PubMedGoogle Scholar
  34. 34.
    Imrie JR, Fagan DG, Sturgess JM (1979) Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol 95: 697–708PubMedGoogle Scholar
  35. 35.
    Jaffe R, Hashida Y, Yunis EJ (1980) Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 42: 356–365PubMedGoogle Scholar
  36. 36.
    Jarotsky AJ (1899) Über die Veränderungen in der Größe und im Bau der Pankreaszellen bei einigen Arten der Inanition. Virchows Arch 155: 409–450Google Scholar
  37. 37.
    Jarousse C, Jeanrenaud B (1982) Functional differences of the endocrine pancreas due to specific blood supply. Diabetologia 23:177Google Scholar
  38. 38.
    Junker K, Egeberg J, Kromann H (1977) An autopsy study of the islets of Langerhans in acute onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand [Sect A] 85: 699–706Google Scholar
  39. 39.
    Karam JH (1982) Obesity and diabetes in humans. In: Brodoff BN, Bleicher SJ (eds) Diabetes mellitus and obesity. Williams and Wilkins, Baltimore, pp 294–400Google Scholar
  40. 40.
    Kawanishi H, Akazawa Y, Machii B (1966) Islets of Langerhans in normal and diabetic humans. Acta Pathol Jpn 16: 177–197PubMedGoogle Scholar
  41. 41.
    Klöppel G, Bommer G, Commandeur G, Heitz PU (1978) The endocrine pancreas in chronic pancreatitis. Virchows Arch [A] 377:157–174CrossRefGoogle Scholar
  42. 42.
    Klöppel G (1981) Endokrines Pankreas und Diabetes mellitus. In: Doerr W, Seifert G (eds) Spezielle pathologische Anatomie, vol 14. Springer, Berlin Heidelberg New York, pp 523–728Google Scholar
  43. 43.
    Klöppel G (1984) Islet histopathology in diabetes mellitus. In: Klöppel G, Heitz PU (eds) Pancreatic Pathology. Livingstone, EdinburghGoogle Scholar
  44. 44.
    Klöppel G, Drenck CR, Oberholzer M, Heitz PU (1984) Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch 403: 441–452CrossRefGoogle Scholar
  45. 45.
    Klöppel G, Lohr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Path Res 4:110–125Google Scholar
  46. 46.
    Kolterman OG, Gray RS, Griffin J (1981) Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 68: 957–969PubMedCrossRefGoogle Scholar
  47. 47.
    Korc M, Owerbach D, Quinto C, Rutter WJ (1981) Pancreatic islet-acinar cell interaction: Amylase messenger RNA levels are determined by insulin. Science 213: 351–353PubMedCrossRefGoogle Scholar
  48. 48.
    Kramer MF, Tan HT (1968) The peri-insular acini of the pancreas of the rat. Z Zellforsch 86: 163–170PubMedCrossRefGoogle Scholar
  49. 49.
    Kraus EJ (1929) Die pathologisch-anatomischen Veränderungen des Pankreas beim Diabetes mellitus. In: Henke F, Lubarsch O (eds) Handbuch der speziellen Pathologischen Anatomie und Histologie. Julius Springer, Berlin, vol 5, Part 2: 622–747Google Scholar
  50. 50.
    Lacy PE (1964) Pancreatic beta cell. In: Aetiology of diabetes mellitus and its complications. Ciba Foundation Colloquia on Endocrinology, Boston, Little, Brown and Company. Vol 15: 75–88Google Scholar
  51. 51.
    Langerhans P (1869) Beiträge zur mikroskopischen Anatomie der Bauchspeicheldrüse. Inaugural Dissertation, Friedrich Wilhelms Universität, BerlinGoogle Scholar
  52. 52.
    Leclercq-Meyer V, Marchand J, Malaisse WJ (1983) Insulin and glucagon release by the perfused ventral and dorsal parts of the rat pancreas. Diabetologia 25:175Google Scholar
  53. 53.
    LeCompte PM (1958) “Insulitis” in early juvenile diabetes. Arch Path 66: 450–457Google Scholar
  54. 54.
    Levine S, Pictet R, Rutter WJ (1973) Control of cell proliferation and cytodifferentiation by a factor reacting with the cell surface. Nature New Biol 246: 49–52PubMedGoogle Scholar
  55. 55.
    Maclean N, Ogilvie RF (1955) Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4: 367–376PubMedGoogle Scholar
  56. 56.
    Maclean N, Ogilvie RF (1959) Observations on the pancreatic islet tissue of young diabetic subjects. Diabetes 8: 83–91PubMedGoogle Scholar
  57. 57.
    Malaisse-Lagae F, Ravazolla M, Robberecht P, Vandermeers A, Malaisse WJ, Orci L (1975) Exocrine pancreas: evidence for topographic partition of secretory function. Science 190: 795–797PubMedCrossRefGoogle Scholar
  58. 58.
    Malaisse-Lagae F, Stefan Y, Cox J, Perrelet A, Orci L (1979 a) Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 17: 361–366PubMedCrossRefGoogle Scholar
  59. 59.
    Malaisse-Lagae F, Orci L, Perrelet A (1979 b) Anatomic and hormonal markers for the ventral primordium in the human pancreas. N Engl J Med 300: 436PubMedGoogle Scholar
  60. 60.
    Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH (1984) Insulin within islets is a physiologic glucagon inhibitor. J Clin Invest 74: 2296–2299PubMedCrossRefGoogle Scholar
  61. 61.
    Maruyama H, Tominaga M, Bolli G, Orci L, Unger RH (1985) The alpha cell response to glucose change during perfusion of anti-insulin serum in pancreas isolated from normal rats. Diabetologia 28: 836–840PubMedCrossRefGoogle Scholar
  62. 62.
    Montesano R, Mouron P, Amherdt M, Orci L (1983) Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids. J Cell Biol 97: 935–939PubMedCrossRefGoogle Scholar
  63. 63.
    Nerup J, Platz P, Anderson O, Christy M, Egeberg J, Lyngsoe J (1976) HLA, autoimmunity and insulin dependent diabetes mellitus. In: Creutzfeld W, Köbberling J, Neel JV (eds) The genetics of diabetes mellitus. Springer, Berlin Heidelberg New York, pp 106–114Google Scholar
  64. 64.
    Ogilvie RF (1933) The islands of Langerhans in 19 cases of obesity. J Pathol Bacteriol 37: 473–481CrossRefGoogle Scholar
  65. 65.
    Olefsky JM (1985) Diabetes mellitus. In: Wyngaarden JB, Smit LH (eds) Cecil textbook of medicine, 17th edn. Saunders, Philadelphia, pp 1320–1339Google Scholar
  66. 66.
    Olefsky JM (1985) Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus. Am J Med 79: 1–7CrossRefGoogle Scholar
  67. 67.
    Opie EL (1900) On the relation of diabetes mellitus to the lesions of the pancreas. Hyaline degeneration of the islets of Langerhans. J Exp Med 5: 397–428CrossRefGoogle Scholar
  68. 68.
    Orci L, Baetens D, Ravazzola M, Stefan Y, Malaisse-Lagae F (1976 a) Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci 19: 1811–1816PubMedCrossRefGoogle Scholar
  69. 69.
    Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, Unger RH (1976 b) Hypertrophy and hyperplasia of somatostatin containing D cells in diabetes. Proc Natl Acad Sci USA 73: 1338–1342PubMedCrossRefGoogle Scholar
  70. 70.
    Orci L, Stefan Y, Malaisse-Lagae F, Perrelet A (1979 a) Instability of pancreatic endocrine cell population throughout the life. Lancet I: 615Google Scholar
  71. 71.
    Orci L, Stefan Y, Malaisse-Lagae F, Perrelet A, Patel Y (1979 b) Pancreatic fat. N Engl J Med 301:1292PubMedGoogle Scholar
  72. 72.
    Palla JC, Abdeljlil AB, Desnuelle P (1968) Action de l’insuline sur la biosynthèse de l’amylase et de quelques autres enzymes du pancréas du rat. Biochim Biophys Acta 158: 25–35PubMedCrossRefGoogle Scholar
  73. 73.
    Pfeifer MA, Halter JB, Porte D (1981) Insulin secretion in diabetes mellitus. Am J Med 70: 579–588PubMedCrossRefGoogle Scholar
  74. 74.
    Pohl MN, Swartz FJ, Carstens PHB (1981) Polyploïdy in islets of normal and diabetic humans. Hum Pathol 12:184–186PubMedCrossRefGoogle Scholar
  75. 75.
    Prosser PR, Karam JH (1978) Diabetes mellitus following rodenticide ingestion in mass. JAMA 239:1148-1150PubMedCrossRefGoogle Scholar
  76. 76.
    Rahier J, Wallon J, Gepts W, Haot J (1979) Localization of pancreatic polypeptide cells in a limited lobe of the human neonate pancreas: Remnant of the ventral primordium? Cell Tissue Res 200: 359–366PubMedCrossRefGoogle Scholar
  77. 77.
    Rahier J, Wallon J (1980) Long cytoplasmic processes in pancreatic polypeptide cells. Cell Tissue Res 209:365–370PubMedCrossRefGoogle Scholar
  78. 78.
    Rahier J, Wallon J, Henquin JC (1980) Abundance of somatostatin cells in the human neonatal pancreas. Diabetologia 18: 251–254PubMedCrossRefGoogle Scholar
  79. 79.
    Rahier J, Wallon J, Henquin JC (1981) Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 20: 540–546PubMedCrossRefGoogle Scholar
  80. 80.
    Rahier J, Wallon J, Haot J (1983 a) A trophic role of pancreatic polypeptide on acinar cells in the human pancreas? Regul Pept [Suppl 2]: S73Google Scholar
  81. 81.
    Rahier J, Wallon J, Loozen S, Lefevre A, Gepts W, Haot J (1983 b) The pancreatic polypeptide cells in the human pancreas: the effects of age and diabetes. J Clin Endocrinol Metab 56: 441–444PubMedCrossRefGoogle Scholar
  82. 82.
    Rahier J, Goebbels RM, Henquin JC (1983 c) Cellular composition of the human diabetic pancreas. Diabetologia 24: 366–371PubMedGoogle Scholar
  83. 83.
    Rahier J, Fält K, Müntefering G, Becker K, Gepts W, Falkmer S (1984) The basic structural lesion of persistent neonatal hypoglycemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells. Diabetologia 26: 282–289PubMedCrossRefGoogle Scholar
  84. 84.
    Reaven GM, Bernstein A, Davis B, Olefsky JM (1966) Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 60: 80–88CrossRefGoogle Scholar
  85. 85.
    Rizza RA, Mandarino LJ, Gerich JE (1981) Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes 30: 990–995PubMedCrossRefGoogle Scholar
  86. 86.
    Romanoff AL (1960) The avian embryo. Structural and functional development. Macmillan, New York, p 527Google Scholar
  87. 87.
    Saito H, Saito S, Sano T, Hosoi E, Saito H (1983) Fetal and maternal plasma levels in immunoreactive somatostatin at delivery: evidence for its increase in the umbilical artery and its arterio-venous gradient in the feto-placental circulation. J Clin Endocrinol Metab 56: 567–571PubMedCrossRefGoogle Scholar
  88. 88.
    Saito K, Yaginuma N, Takahashi T (1979) Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 129: 273–283PubMedCrossRefGoogle Scholar
  89. 89.
    Scarlett JA, Gray RS, Griffin J, Olefsky J, Kolterman OG (1982) Insulin treatment reverses the insulin resistance of Type II diabetes mellitus. Diabetes Care 5: 353–363PubMedGoogle Scholar
  90. 90.
    Schmidt MB (1902) Über die Beziehung der Langerhansschen Inseln des Pancreas zum Diabetes mellitus. Münch Med Wochenschr 49: 51–54Google Scholar
  91. 91.
    Seifert G (1959) Die pathologische Morphologie der Langerhansschen Inseln, besonders beim Diabetes mellitus des Menschen. Verh Dtsch Gesamt Pathol 18: 50–84Google Scholar
  92. 92.
    Shwachman H, Diamond LK, Oski FA (1964) The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 65: 645PubMedCrossRefGoogle Scholar
  93. 93.
    Sibley RK, Sutherland DER, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132–144PubMedGoogle Scholar
  94. 94.
    Söling HD, Unger KO (1972) The role of insulin in the regulation of alpha-amylase synthesis in the rat pancreas. Eur J Clin Invest 2:199–212PubMedCrossRefGoogle Scholar
  95. 95.
    Spooner BS, Walther BT, Rutter WJ (1970) The development of the dorsal and ventral mammalian pancreas in vivo and in vitro. J Cell Biol 47: 235–246PubMedCrossRefGoogle Scholar
  96. 96.
    Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH (1982) Quantification of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31: 694–700PubMedCrossRefGoogle Scholar
  97. 97.
    Testut L, Latarjet A (1949) Traité d’anatomie humaine, vol 4, 9th edn. Douin, Paris, pp 712–713Google Scholar
  98. 98.
    Trimble ER, Renold AE (1981) Ventral and dorsal areas of rat pancreas: islet hormone content and secretion. Am J Physiol 240: E422–E427PubMedGoogle Scholar
  99. 99.
    Trimble ER, Halban PA, Wollheim CB, Renold AE (1982) Functional differences between rat islets of ventral and dorsal pancreatic origin. J Clin Invest 69: 405–413PubMedCrossRefGoogle Scholar
  100. 100.
    Unger RH, Aguilar-Parada E, Muller WA, Eisentraut AM (1970) Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49: 837–848PubMedCrossRefGoogle Scholar
  101. 101.
    Unger RH, Grundy S (1985) Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119–121PubMedCrossRefGoogle Scholar
  102. 102.
    Unger RH, Orci L (1975) Hypothesis: the essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet 1:14–16PubMedCrossRefGoogle Scholar
  103. 103.
    Van Assche FA, Aerts L (1979) The fetal endocrine pancreas. Contrib Gynecol Obstet 5: 44–57PubMedGoogle Scholar
  104. 104.
    Vartiainen I (1944) Studien über den Diabetes mellitus in Finnland: die makroskopischen Organveränderungen der Diabetiker im Lichte des Obduktionsmaterials. Acta Med Scand 118: 538–589CrossRefGoogle Scholar
  105. 105.
    von Mering S, Minkowski O (1889) Diabetes mellitus nach Pankreasexstirpation. Arch Exp Pathol Pharmakol 26: 371–387Google Scholar
  106. 106.
    von Meyenburg H (1940) Über “Insulitis” bei Diabetes. Schweiz Med Wochenschr 21: 554–557Google Scholar
  107. 107.
    Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D (1984) Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 7: 491–502PubMedCrossRefGoogle Scholar
  108. 108.
    Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D (1984) Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 74:1318–1328PubMedCrossRefGoogle Scholar
  109. 109.
    Warren S, Root HF (1925) The pathology of diabetes, with special reference to pancreatic regeneration. Am J Pathol 1: 415–430PubMedGoogle Scholar
  110. 110.
    Warren SH, LeCompte PH (1952) The pathology of diabetes mellitus, 3rd edn. Kimpton, London, pp 53Google Scholar
  111. 111.
    Weichselbaum A, Stangl E (1901/02) Zur Kenntnis der feineren Veränderungen des Pankreas bei Diabetes mellitus. Wien Klin Wochenschr 14: 968Google Scholar
  112. 112.
    Wessells NK, Cohn IH (1967) Early pancreas organogenesis: morphogenesis, tissue interactions and mass effects. Dev Biol 15: 237–270CrossRefGoogle Scholar
  113. 113.
    Westermark P (1972) Quantitative studies of amyloid in the islets of Langerhans. Upsal J Med Sci 77: 91–94Google Scholar
  114. 114.
    Westermark P (1973) Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch 359: 1–18Google Scholar
  115. 115.
    Westermark P (1977) Amyloïd of human islets of Langerhans. Virchows Arch 373: 161Google Scholar
  116. 116.
    Westermark P, Wilander E (1978) The influence of amyloid deposits in the islets volume in maturity onset diabetes mellitus. Diabetologia 15: 417–421PubMedCrossRefGoogle Scholar
  117. 117.
    Westermark P, Wilander E (1983) Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia 24: 342–346PubMedCrossRefGoogle Scholar
  118. 118.
    White JW, Swartz FJ, Swartz AF (1985) Excess glucose intake induces accelerated B cell polyploidisation in normal mice: a possible deleterious effect. J Nutr 115: 271–278PubMedGoogle Scholar
  119. 119.
    World Health Organisation expert committee on diabetes mellitus (1980) Second report. Technical report series. WHO, GenevaGoogle Scholar
  120. 120.
    Yoon JW, Austin M, Onodera R, Notkins AL (1979) Virus induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173–1179PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • J. Rahier

There are no affiliations available

Personalised recommendations